Klara Dickinson

Klara A. Dickinson is the Chief Regulatory and Compliance Officer at CymaBay Therapeutics.

Ms. Dickinson previously spent 3 years with CoTherix, Inc. and most recently served as VP, Regulatory Affairs and Healthcare Compliance Officer for the company.

In that role, Ms. Dickinson led the filing of the NDA and label negotiations for the company’s initial product, Ventavis® (iloprost) Inhalation Solution.

Ms. Dickinson has also held various positions at Scios, Inc. and Dey Laboratories, a subsidiary of Mylan Inc.

Ms. Dickinson holds a BS in biology from the College of Great Falls in Montana and is certified by the Regulatory Affairs Certification Board.

Klara Dickinson is the Chief Regulatory and Compliance Officer at CymaBay Therapeutics, based in United States, North America. With a background in Biotechnology, Klara Dickinson has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.